Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon Names New Research Veep; Venter Makes Himself Comfy with U.S. Genomics; and Others

NEW YORK, Aug. 20 - Lexicon Genetics yesterday said that Brian Zambrowicz has been promoted to executive vice president of research.

 

Zambrowicz was previously the company's senior vice president of genomics.

 


 

U.S. Genomics has added Craig Venter to its board of directors and named him as a scientific advisor, the company said last week.

 

This is Venter's first such job in a private-sector setting since leaving Celera in January.

 


 

Paradigm Genetics has chosen Thomas Colatsky as its new vice president of health-care research, the company said on Aug. 12.

 

Colatsky was previously president and CEO of Argolyn Bioscience, a company focused on the design and development of peptide drugs and diagnostics.

 



Promoted? Changing jobs? GenomeWeb wants to know. E-mail Kathleen McGowan at [email protected] to appear in PEOPLE, a roundup of personnel comings and goings in genomics, that runs every Wednesday.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.